Financials
Overview
Mdxhealth operates on a calendar basis with its accounting year ending on Dec. 31. The company reports its consolidated financial statements under International Financial Reporting Standards (IFRS) and all amounts are in US Dollars. Mdxhealth publishes a consolidated and audited Annual Report on an annual basis, a consolidated Interim Report for its June 30 half-year financial figures, and business/financial updates at the end of Q1 and Q3.
Furthermore, for the Annual General Shareholders’ Meeting, the company also publishes the non-consolidated Belgian-GAAP financial statements of the parent company. Prior to October 5, 2010, mdxhealth operated under the name OncoMethylome Sciences.
Financial Reports
Consolidated figures for the first quarter ended March 31, 2025: English
2024
Consolidated figures for the first quarter ended March 31, 2024: English
Interim report for the six months ended June 30, 2024: English
Consolidated figures for the periods ended September 30, 2024: English
2024 Annual Report on Form 20-F: English
2023 Combined Statutory and Consolidated Board Report: English I Francais
2023 Full Non-consolidated Statutory Accounts: Francais
2023
2023 Consolidated figures for the First quarter ended March 31, 2023: English I Français
2023 Interim Report for the six months ended June 30, 2023: English I Français
2023 Financial statements for the periods ended September 30, 2023: English
2023 Annual Report on Form 20-F: English
2023 Combined Statutory and Consolidated Board Report: English I Francais
2023 Full Non-consolidated Statutory Accounts: Francais
2022
2022 Interim Report for the six months ended June 30, 2022: English I Français
2022 Interim Report for the nine months ended September 30, 2022: English
2022 Consolidated Figures: English
2022 Combined Statutory and Consolidated Board Report: English I Français
2022 Full Non-consolidated Statutory Accounts: Français
2022 Annual Report: English I Français
2022 Annual Report (XBRL ZIP): English I Français I View XBRL
2021
2021 Interim Report: English I Français
2021 Consolidated Figures: English
2021 Board Report on Financial Statements: English I Français
2021 Full Non-consolidated Statutory Accounts: Français
2021 Annual Report (PDF): English I Français
2021 Annual Report (XBRL ZIP): English | Français I View XBRL
2020
2020 Interim Report: English I Français
2020 Consolidated Figures: English
2020 Board Report on Financial Statements: English I Français
2020 Full Non-consolidated Statutory Accounts: Français
2019
2019 Interim Report: English | Français
2019 Consolidated Figures: English
2019 Board Report on Financial Statements: English I Français
2019 Full Non-consolidated Statutory Accounts: Français
SEC Filings
Investor Relations Contact
For all investor related questions please call or email:
LifeSci Advisor (PR & IR)
US: +1.949.271.9223
ir@mdxhealth.com
